BioPharma Credit PLC

BPCP.L · LSE
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income£73£50£72£38
Dep. & Amort.£0£0£0£0
Deferred Tax£0£0£0£0
Stock-Based Comp.£0£0£0£0
Change in WC-£23£6-£17£19
Other Non-Cash-£25£8-£8£36
Operating Cash Flow£25£64£48£93
Investing Activities
PP&E Inv.£0£0£0£0
Net Acquisitions£0£0£0£0
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£39£0£0
Other Inv. Act.£51-£39£39£0
Investing Cash Flow£51-£0£39£0
Financing Activities
Debt Repay.£0£0£0£0
Stock Issued£0£0£0£0
Stock Repurch.-£37-£29-£77-£3
Dividends Paid-£40-£67-£108-£23
Other Fin. Act.£0£0£0£0
Financing Cash Flow-£105-£96-£185-£26
Forex Effect-£0-£0£0-£0
Net Chg. in Cash-£1-£37-£49£34
Supplemental Information
Beg. Cash£4-£49£0£68
End Cash£3£6-£49£135
Free Cash Flow£25£64£48£93
BioPharma Credit PLC (BPCP.L) Financial Statements & Key Stats | AlphaPilot